Immunohistochemical localization of C‐reactive protein‐binding sites in human atherosclerotic aortic lesions by a modified streptavidin‐biotin‐staining method
暂无分享,去创建一个
C. Yutani | Xiangan Li | K. Masuda | K. Hatanaka | A. Yamamoto | X. Li
[1] H. Ishibashi-Ueda,et al. Characterization of serum amyloid P component from human aortic atherosclerotic lesions. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[2] A. Gown,et al. Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies , 1994, Circulation.
[3] T. Blundell,et al. Structure of pentameric human serum amyloid P component , 1994, Nature.
[4] Y. Zhang,et al. Plasma protein insudation as an index of early coronary atherogenesis. , 1993, The American journal of pathology.
[5] C. Yutani,et al. Ultrastructural studies on the phenotypic modulation of human intimal smooth muscle cells. , 1993, Atherosclerosis.
[6] M. Jacob,et al. Cell‐Matrix Interactions in the Genesis of Arteriosclerosis and Atheroma , 1992, Annals of the New York Academy of Sciences.
[7] C. Mold,et al. Serum amyloid P component binds to histones and activates the classical complement pathway. , 1992, Journal of immunology.
[8] P. Libby,et al. Cytokines and growth factors in atherogenesis. , 1992, Archives of pathology & laboratory medicine.
[9] R. Christner,et al. A cell attachment peptide from human C‐reactive protein , 1992, Journal of cellular biochemistry.
[10] T. Ueno,et al. Complement receptors in atherosclerotic lesions. , 1992, Artery.
[11] N. Ku,et al. Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-beta. , 1990, Journal of immunology.
[12] P. Butler,et al. Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin , 1990, The Journal of experimental medicine.
[13] I. Kushner,et al. C-reactive protein and the acute-phase response. , 1990, Hospital practice.
[14] N. Goldman,et al. cis-acting elements responsible for interleukin-6 inducible C-reactive protein gene expression. , 1990, The Journal of biological chemistry.
[15] G. Ciliberto,et al. Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6. , 1989, The EMBO journal.
[16] G. Hansson,et al. Complement receptors and regulatory proteins in human atherosclerotic lesions. , 1989, Arteriosclerosis.
[17] T. D. Du Clos,et al. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. , 1989, Journal of immunology.
[18] G. Hansson,et al. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[19] T. D. Du Clos. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. , 1989, Journal of immunology.
[20] T. D. Du Clos,et al. Analysis of the binding of C-reactive protein to histones and chromatin. , 1988, Journal of immunology.
[21] Reynolds Gd,et al. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. , 1987 .
[22] R. Vance,et al. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. , 1987, Archives of pathology & laboratory medicine.
[23] G. Gabbiani,et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation , 1986, The Journal of cell biology.
[24] H. Rus,et al. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. , 1986, Atherosclerosis.
[25] H. Rus,et al. Immunoglobulins and complement components in human aortic atherosclerotic intima. , 1985, Atherosclerosis.
[26] M. Pepys,et al. Immunohistochemical studies of c‐reactive protein and apolipoprotein b in inflammatory and arterial lesions , 1985, Journal of Pathology.
[27] M. Pepys,et al. Circulating human C-reactive protein binds very low density lipoproteins. , 1984, Clinical and experimental immunology.
[28] A. Feinstein,et al. Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins , 1984, The Journal of experimental medicine.
[29] M. Pepys,et al. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.
[30] A. Feinstein,et al. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein , 1982, The Journal of experimental medicine.
[31] J. Volanakis,et al. C‐REACTIVE PROTEIN BINDING SPECIFICITIES: ARTIFICIAL AND NATURAL PHOSPHOLIPID BILAYERS * , 1982, Annals of the New York Academy of Sciences.
[32] C. Mold,et al. C-reactive protein and the acute phase response. , 1982, Advances in internal medicine.
[33] R. Mortensen,et al. Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors. , 1977, Journal of immunology.
[34] T. Lint,et al. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. , 1976, Journal of immunology.
[35] H. Gewurz,et al. Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP , 1975, The Journal of experimental medicine.
[36] H. Gewurz,et al. INTERACTIONS OF C-REACTIVE PROTEIN WITH THE COMPLEMENT SYSTEM , 1974, The Journal of experimental medicine.